Medical Devices Acquisitions in Massachusetts

An independently managed investment subsidiary of Investindustrial Growth III SCSp has acquired Proveris Scientific Corporation, a Hudson, Massachusetts-based maker of spray and aerosol analytical testing instrumentation, software and lab services focused on orally inhaled and nasal drug products (OINDP). Investindustrial will partner with Proveris' management (founder Dino Farina reinvested as a minority shareholder) to accelerate global expansion and build a broader pharmaceutical testing equipment group through organic growth and add-on acquisitions.

Aptyx has acquired Argos Corporation, a Massachusetts-based precision extrusion specialist, and will establish a Boston-area Precision Extrusion Center of Excellence to expand medical tubing and catheter-grade extrusion capacity. The deal enhances Aptyx’s capabilities for interventional and catheter-based device markets, adding in-house tooling and micro-extrusion expertise to its integrated medical manufacturing platform.

Evident has completed its acquisition of Pramana, Inc., a Cambridge-based developer of autonomous whole slide imaging systems for digital pathology. The deal brings Pramana's AI-powered imaging and workflow technology into Evident's microscopy and optical-imaging portfolio to accelerate digital pathology capabilities and broaden solutions for hospitals, research institutions, and laboratories.

Keensight Capital has acquired a majority stake in Isto Biologics, a US-based regenerative MedTech company focused on orthobiologic bone graft solutions. Thompson Street Capital Partners will retain a minority stake alongside Isto's management; Keensight plans to support Isto's international expansion and pursue additional acquisitions to accelerate growth.

Biogen has acquired Alcyone Therapeutics to obtain the ThecaFlex DRx intrathecal drug‑delivery system, integrating Alcyone employees into Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus contingent milestone payments; Biogen will handle development, commercialization and manufacturing of ThecaFlex DRx while Alcyone’s remaining therapeutic assets are being divested into Neela Therapeutics.

HKW, a middle-market private equity firm, has partnered with the Cherubini family to recapitalize AliMed Inc., a Dedham, Massachusetts-based manufacturer and distributor of medical products. The recapitalization will support AliMed's organic growth and enable the company to pursue acquisitions and further develop its digital and manufacturing capabilities.

Demetra S.p.A. has completed the full acquisition of OrthoFundamentals, LLC, a U.S.-based maker of sterile-packed, single-use implants and instrument kits for sacroiliac (SI) joint fusion. The deal enables Demetra to launch Demetra Spine, expanding its product offering into spine surgery and strengthening its presence in the U.S. outpatient Ambulatory Surgery Center (ASC) market.

Quanterix Corporation has completed its acquisition of Akoya Biosciences, combining Quanterix's ultra‑sensitive blood biomarker detection platform with Akoya's spatial biology imaging and reagents. Under the amended merger agreement, Quanterix issued approximately 7.8 million shares and paid about $20 million in cash to Akoya equity holders; the combined business is expected to expand the company's served addressable market and accelerate the path to profitability.

Ampersand Capital Partners has made a strategic growth investment in Lexington Medical, a Bedford, Massachusetts-based designer and manufacturer of minimally invasive surgical stapling devices. The investment will support Lexington's product innovation, smart manufacturing initiatives, and global market expansion while bolstering the company's US-based manufacturing and talent base.

Advanced Instruments, a subsidiary of Patricia Industries, has acquired Nova Biomedical for an enterprise value of USD 2.2 billion. The combined business will operate under the Nova Biomedical name, be led by Advanced Instruments CEO Byron Selman, and creates a diversified global life-science tools platform serving biopharmaceutical and clinical markets.

Astorg completed a take-private of Hamilton Thorne and simultaneously acquired Cook Medical’s Reproductive Health business, combining the two to create a global leader in assisted reproductive technology (ART) consumables, instruments and equipment. The combined company will serve fertility clinics and IVF laboratories in over 115 countries, with a new executive team appointed to lead the integrated MedTech platform.

Primo Medical Group, together with former Arthrosurface executives and a newly formed parent company Phoenix Brio, acquired Arthrosurface, a maker of joint restoration and preservation implants, from Anika Therapeutics. The deal returns Arthrosurface to independent ownership with Phoenix Brio as the parent and operations based in West Bridgewater, Massachusetts.

Vitalograph, the family-owned respiratory diagnostics company based in Ennis, Ireland, has acquired Massachusetts-based Morgan Scientific, the developer of ComPAS2 software and a long-standing U.S. distributor for Vitalograph. The acquisition strengthens Vitalograph’s U.S. commercial footprint and integrates Morgan Scientific’s PFT software capabilities to support growth in advanced pulmonary function testing solutions globally.

Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

CooperCompanies, through its CooperSurgical business, has acquired obp Surgical, a U.S.-based maker of single-use cordless surgical retractors and suction devices, for approximately $100 million. obp Surgical's ONETRAC products generated roughly $14.5 million of trailing twelve-month revenue; Cooper said the acquisition will be neutral to non-GAAP EPS in fiscal 2024 and accretive thereafter and will be reported in its Office and Surgical category.

Virtual Therapeutics completed a tender offer to acquire all outstanding shares of Akili, Inc. for $0.4340 per share, with approximately 88.2% of Akili's shares tendered. Following acceptance of the tendered shares, Virtual Therapeutics' wholly owned subsidiary Alpha Merger Sub will merge into Akili, making Akili a wholly owned subsidiary and prompting Nasdaq delisting and deregistration.

Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.

Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.

restor3d, a Durham-based maker of 3D-printed patient-specific musculoskeletal implants, completed its acquisition of Conformis, Inc., a Billerica, Massachusetts-based personalized joint replacement company. The deal adds Conformis' hip and knee implant portfolio and patient-specific technologies to restor3d's capabilities, enabling lower-cost, 3D-printed femoral implants and expanded orthopedic product offerings.

OrthoPediatrics Corp. (Nasdaq: KIDS) acquired Boston Orthotics & Prosthetics, a pediatric orthotic management company with 26 clinics and approximately $25 million in annual revenue, for $22 million in cash. The deal expands OrthoPediatrics' Specialty Bracing division and was supported by a new $80 million credit facility with MidCap Financial.

PerkinElmer has acquired Covaris, a Woburn, Massachusetts-based developer of instruments, consumables, and reagents for high-throughput genomic and proteomic sample preparation. Both companies are majority owned by New Mountain Capital; the acquisition expands PerkinElmer's life-sciences portfolio and accelerates its entry into the diagnostics and NGS sample-preparation market. Terms were not disclosed.

Boston Scientific Corporation agreed to acquire Relievant Medsystems, Inc. to expand its neuromodulation portfolio and add the Intracept intraosseous nerve ablation system for vertebrogenic chronic low back pain. The deal includes an $850 million upfront cash payment plus contingent payments tied to sales, and is expected to close in the first half of 2024; Relievant was projected to generate more than $70 million in sales in 2023.

Arterex (Medical Device, Inc.), an Investindustrial-backed medical device contract manufacturer, has acquired NextPhase Medical Devices from Kidd & Company, LLC. The deal expands Arterex’s global multi-capability platform — nearly doubling the group’s scale and adding complementary design, engineering and complex electromechanical and implantable device manufacturing capabilities across North America and internationally.

Zeon Corporation, through its U.S. subsidiary Zeon Specialty Materials Inc., purchased 100% of Edge Precision Manufacturing, Inc., a Massachusetts-based manufacturer of micro‑featured thermoplastic disposables, on December 28, 2022. The acquisition strengthens Zeon's cyclo olefin polymer (COP) offering for microfluidic and diagnostic devices by combining Zeon's materials with Edge's precision compression‑molding capabilities and customer network.

Johnson & Johnson completed its acquisition of Abiomed on December 22, 2022, acquiring all outstanding shares for $380.00 per share (approximately $16.6 billion enterprise value) plus a contingent value right. Abiomed will operate as a standalone business within Johnson & Johnson's MedTech segment, expanding J&J's capabilities in high-growth cardiovascular and heart-recovery solutions.

Pion Inc., a provider of analytical instruments for drug development and backed by SFW Capital, has acquired Two Square Science, a Fall River, Massachusetts company that designs sample preparation and lab monitoring equipment. The acquisition adds Two Square's PrepEngine and LabEye technologies to Pion's product portfolio to expand in vitro sample preparation and remote monitoring capabilities and accelerate customers' drug development workflows.

GCX Mounting Solutions, a portfolio company of Audax Private Equity, has acquired Jaco, Inc., a Franklin, Massachusetts-based manufacturer of point-of-care IT workstations and powered carts. The add-on acquisition expands GCX's medical mounting and OEM manufacturing capabilities—adding Jaco's battery-powered EVO Series mobile carts and complementary commercial and manufacturing competencies; financial terms were not disclosed.

Pion Inc. has acquired BEE International, adding high-pressure homogenization and emulsification equipment to Pion’s portfolio of formulation and analytical tools for biopharmaceutical development. BEE International will operate as an independent business unit and continue supporting customers from its South Easton, Massachusetts headquarters.

EPTAM Precision Solutions, a Frazier Healthcare Partners portfolio company, has acquired Sterling Manufacturing and its wholly owned subsidiary Albright Silicone to expand its thermoplastic and liquid silicone rubber (LSR) molding capabilities. The deal strengthens EPTAM's footprint in medical device, molecular diagnostics and biopharma markets by adding tooling, LSR expertise and complementary molding capacity in Massachusetts.

North Haven Capital, in partnership with Upstream Capital and with financing support from BankProv and BDC Capital, has acquired The Chamberlain Group, a New England-based designer and manufacturer of high-fidelity anatomical medical models. The deal gives North Haven a control position to expand TCG’s product offerings, service capabilities, target end markets and international footprint while working with the company’s founders and existing team.

New Mountain Capital entered into a definitive agreement to acquire PerkinElmer's Applied, Food and Enterprise Services businesses (a carve-out from PerkinElmer's Discovery & Analytical Solutions segment) for up to $2.45 billion. The transaction transfers the OneSource lab and field services business and a portfolio of instruments, consumables and reagents to New Mountain, which intends to invest behind the business as a platform for growth; the deal closed in Q1 2023 subject to customary approvals.

ARCH Medical Solutions, a Jordan Company platform, has acquired M&K Engineering of Woburn, Massachusetts. The add-on strengthens ARCH's precision medical manufacturing capabilities by adding vertically integrated CNC and robotic machining capacity that serves medical, aerospace and defense markets.

Ivenix, Inc. has entered into a definitive agreement to be acquired by Fresenius Kabi for an upfront payment of $240 million plus additional milestone payments. The deal brings Ivenix's next-generation infusion pump technology and software together with Fresenius Kabi's IV fluids and infusion therapy portfolio to create a comprehensive infusion offering and accelerate U.S. commercial expansion.

New Mountain Capital has made a majority investment in Covaris, a Woburn, Massachusetts-based manufacturer of sample preparation instruments, consumables and reagents for genomics and proteomics. Founder Jim Laugharn will remain CEO and Chris O'Connell will serve as Executive Chairman as New Mountain partners with Covaris to accelerate growth and expand the company's sample-prep capabilities.

Arlington Capital Partners, a Washington, DC-based private equity firm, has acquired Millstone Medical Outsourcing, a Fall River, Massachusetts-based provider of post-manufacturing, quality-critical services and supply chain logistics to medical device and pharmaceutical manufacturers. Selling shareholders included Schooner Capital; Arlington said it will provide strategic and capital support to accelerate Millstone's organic growth and pursue strategic acquisitions.

ChargePoint Technology Ltd., a portfolio company of Arcline Investment Management, has acquired Terracon Corporation, a Franklin, Massachusetts-based manufacturer of single-use liquid mixing, transfer, and storage products for the biopharma and life science markets. The acquisition adds Terracon’s ISO 9001-certified single-use liquid handling and containment capabilities to ChargePoint’s pharma-focused transfer technologies as an add-on to the ChargePoint platform.

General Electric Company (through GE HealthCare) has acquired BK Medical from Altaris Capital Partners for a cash purchase price of $1.45 billion. The acquisition brings BK Medical's intraoperative ultrasound and surgical visualization capabilities into GE Healthcare's ultrasound portfolio, expanding GE's offering from diagnostics into surgical and therapeutic interventions.

Becton, Dickinson and Company (BD) has acquired Tepha, Inc., a developer and manufacturer of a proprietary resorbable polymer (P4HB) and the GalaFLEX product portfolio, to strengthen BD's surgical mesh offerings. The deal provides BD with vertical integration of a key supply-chain component for its Phasix Mesh products and supports capability expansion into soft tissue repair, reconstruction and regeneration; terms were not disclosed.

NextPhase Medical Devices LLC has acquired Proven Process Medical Devices Inc., adding R&D, engineering, design and FDA Class II/III manufacturing capabilities to NextPhase's existing EMS and disposable device services. The acquisition expands NextPhase's technology platform and New England manufacturing footprint, enabling broader product offerings across implantables, wearable and electromechanical devices while optimizing customer supply chains.

SFW Capital Partners completed a majority recapitalization of Pion Inc., a Billerica, Massachusetts-based provider of analytical instrumentation, software, reagents and services for pharmaceutical formulation development and quality control. Founders Mike and Sharon Kelly are reinvesting and will retain an ownership stake while Brian Dutko was named CEO as the company pursues product development, international expansion, enhanced sales and marketing, and strategic acquisitions.

PerkinElmer, Inc. agreed to acquire Nexcelom Bioscience for $260 million in cash, a deal announced in 2021 and completed in June 2021. Nexcelom, a Lawrence, Massachusetts–based maker of automated cell counters, image cytometry systems, consumables and reagents (~130 employees, projected 2021 revenue ~$40M), was owned by its founders and Ampersand Capital Partners.

Wave Imaging Solutions acquired Encore Technical Services, Inc., a North Attleboro, Massachusetts-based medical equipment sales and service contractor, in a transaction that closed April 30, 2021. The deal expands Wave's ultrasound sales, service and parts capabilities by adding Encore's recurring service and maintenance contracts, technician team and parts inventory.

TEAM Technologies, a Clearlake-backed healthcare specialty manufacturer, acquired ViruDefense, a Burlington, MA-based maker of domestically produced N95 respirators. The add-on expands TEAM's infection prevention and control portfolio and brings additional domestic N95 manufacturing capacity and a CDC-certified product into TEAM's platform.

GTCR, together with management partner Gregory T. Lucier (Corza Health), acquired Surgical Specialties Corporation and the TachoSil fibrin sealant patch product line from Takeda and merged them to form Corza Medical. The new company, headquartered in Westwood, Massachusetts, operates in 13 countries with manufacturing in the U.S., Mexico, England, Germany and China and a global team of over 1,700 employees.

Royal Philips agreed to acquire Capsule Technologies, a portfolio company of Francisco Partners, for $635 million in cash. The deal will fold Capsule — a developer of medical device integration, patient monitoring, and clinical surveillance software used by hospitals worldwide — into Philips' Connected Care segment; Capsule has roughly 300 employees and serves more than 2,800 hospitals in 40 countries.

Avista Capital Partners, a New York-based private equity firm focused on healthcare, has completed its acquisition of Solmetex, the leading provider of amalgam separators and dental waste-compliance products and services. The deal (terms undisclosed) transfers ownership from prior investors including AVALT and Gemini Investors (and referenced Riveria Investment Group), with Avista planning to invest in product development and accelerate domestic and international expansion.

German life‑science group Sartorius, via its subgroup Sartorius Stedim Biotech, has acquired U.S.-based purification specialist WaterSep BioSeparations LLC. The deal, valued at approximately $27 million plus an earn‑out of up to $9 million, adds hollow‑fiber crossflow filtration and single‑use bioprocessing devices aimed at gene and cell therapy, vaccine production and intensified bioprocessing to Sartorius' separation portfolio.

Motion Dynamics LLC, a portfolio company of Vance Street Capital, has acquired ViaMed Holdings LLC in the platform’s first strategic add‑on acquisition. The deal expands Motion Dynamics’ micro‑precision manufacturing capabilities (coiling, braiding, nitinol shape‑setting) for medical device OEMs and contract manufacturers; terms were not disclosed.

Paramit Corporation, a portfolio company of Altaris Capital Partners, acquired Emphysys, Inc., a Boston-area technology development firm specializing in medical device, life sciences and industrial product development. The acquisition expands Paramit's upstream product development capabilities and adds a Greater Boston presence to support growth in medical device and life sciences markets.

Patricia Industries, part of Investor AB, has completed the acquisition of US-based Advanced Instruments, a global leader in osmolality testing instrumentation and consumables, from Windjammer Capital. The deal values Advanced Instruments at an enterprise value of USD 780 million; Patricia Industries injected roughly USD 619–620 million of equity for majority ownership. Advanced Instruments (headquartered in Norwood, Massachusetts) serves clinical, biopharmaceutical and food & beverage markets and reported approximately USD 72 million in sales for the 12 months ending June 30, 2020.